Please provide your email address to receive an email when new articles are posted on . Rezpegaldesleukin is an interleukin-2 receptor pathway agonist that has shown success in other autoimmune ...
Prime Minister Mark Carney moved to speed up national priorities, recommending six new projects for fast-track approval in a bid to accelerate delivery and signal momentum on growth. The announcement ...
HDP-101, an ADC, received FDA fast track designation for multiple myeloma, highlighting its potential in addressing unmet medical needs. Phase 1/2a trials show HDP-101's promising efficacy and ...